In today’s fast-paced pharmaceutical industry, efficiency and innovation are key to staying ahead. Farmson, a leader in Active Pharmaceutical Ingredient (API) production, has consistently demonstrated its commitment to meeting the evolving needs of its customers. In line with this commitment, Farmson has embarked on a significant new venture: the production of Directly Compressible (DC) granules. This forward integration marks a strategic move to offer end-to-end solutions, from API to tablet compressible formulation.

Why Directly Compressible Granules?

Directly compressible granules are essential in the pharmaceutical industry for producing tablets. These granules are designed to be easily compressed into tablets without the need for additional processing steps, making the manufacturing process more efficient and cost-effective. By producing DC granules in-house, Farmson can ensure a seamless transition from API production to the final tablet form, enhancing product quality and consistency.

Drum-to-Feeder Solutions: Simplifying Tablet Production

One of the standout features of Farmson’s DC granules is their drum-to-feeder compatibility. This feature allows for a straightforward compression or encapsulation process, reducing operational complexity and enhancing economic viability for pharmaceutical manufacturers. With this solution, Farmson aims to simplify the production process for its customers, ensuring they can produce high-quality tablets with minimal hassle.

State-of-the-Art DC Plant with GLATT Granulation Lines

Farmson’s DC granules are produced in a cutting-edge facility equipped with fully integrated GLATT granulation lines. GLATT is renowned for its advanced technology in the pharmaceutical industry, ensuring that Farmson’s DC granules meet the highest standards of quality and performance. This investment in state-of-the-art equipment underscores Farmson’s commitment to innovation and excellence.

Customized DC Granules to Meet Specific Needs

Understanding that every customer has unique requirements, Farmson also offers tailor-made DC granules . This customization allows pharmaceutical companies to create formulations that are specifically designed to meet their needs, providing greater flexibility in product development and manufacturing. (https://www.farmson.com/products/paracetamol_dc) 

Farmson’s venture into the production of directly compressible granules is a testament to its dedication to providing comprehensive solutions to the pharmaceutical industry. By offering a seamless transition from API to tablet compressible formulation, Farmson is not only enhancing its product portfolio but also strengthening its position as a trusted partner in the pharmaceutical supply chain. With advanced technology, economically sound solutions, and a focus on customer needs, Farmson is poised to set new standards in the industry.